The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
CORONARY INTERVENTIONS
Potentially increased incidence of scaffold thrombosis in patients treated with Absorb BVS who terminated DAPT before 18 months
EuroIntervention 2017;13:e177-e184 published online ahead of print May 2017 published online e-edition June 2017. DOI: 10.4244/EIJ-D-17-00119
Cordula M. Felix1, MD; Georgios J. Vlachojannis2, MD, PhD; Alexander J.J. IJsselmuiden3, MD, PhD; Jiang M. Fam4, MD; Peter C. Smits2, MD, PhD; Wouter J. Lansink3, Msc; Roberto Diletti1, MD, PhD; Felix Zijlstra1, MD, PhD; Evelyn S. Regar1, MD, PhD; Eric Boersma1, PhD; Yoshinobu Onuma1, MD, PhD; Robert J.M. van Geuns1*, MD, PhD
1. Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands; 2. Maasstad Hospital, Rotterdam, the Netherlands; 3. Albert Schweitzer Hospital, Dordrecht, the Netherlands; 4. National Heart Centre Singapore, Singapore
Aims: The aim of this study was to investigate the impact of dual antiplatelet therapy (DAPT) termination on late and very late scaffold thrombosis (ScT) in patients treated with the Abso